“One is to have an external set of things that get to look at all of the model's actions and subject them to a symbolic, clearly stated constraint.”
BG
Bill Gates
Decoder with Nilay Patel ·
The AI in Business Podcast · Turning Biological Complexity into R&D Advantage with Virtual Cells - with Giorgio Gaglia of Sanofi & Daniel Veres of Turbine
Audio streams from the publisher’s own feed. Verbatim does not host or copy it.
state that virtual cell predictions can reduce the number of in-vitro experiments needed while still covering a wider set of models
“One is to have an external set of things that get to look at all of the model's actions and subject them to a symbolic, clearly stated constraint.”
“If you have that set up, the moment that that happens, you fall back immediately and your users don't experience anything to a different model”
“We trained models on internal data and then predicted on external data… total number of tests … like 13 million across 500 protein targets.”
“Selling enough to cover the profit you need ... popular and profitable ... we raised the price, bought feed in bulk, still losing money”
The strongest new moments on your topics, in the speakers' own words. Free for three topics.
No card. No password. One-click unsubscribe.
Pro watches up to 25 names or phrases and emails you the morning after they are said.
See Pro, $29 a monthVerbatim quotes a short extract and links to the episode; the episode belongs to its publisher. Remove a show.